Key Highlights
- Ria Health adds Dr. Martin Rosenzweig to its Board of Directors.
- Former Optum Behavioral Health CMO brings 25+ years of expertise.
- Focus on expanding telehealth access for Alcohol Use Disorder (AUD).
- Ria Health’s platform combines physician support, FDA-approved medication, and monitoring tools.
- Commitment to compassionate, scalable treatment amid rising alcohol misuse rates.
Source: Business Wire
Notable Quotes
- “I am excited to join Ria Health’s board and support an organization that is making tremendous advancements in the treatment of alcohol use disorder.” — Dr. Martin Rosenzweig, Board Member at Ria Health
- “We are thrilled to have Martin join us on the board. His wealth of knowledge and experience in behavioral health align perfectly with Ria Health’s mission.” — Carol Vallone, Chair of the Board at Ria Health
- “Martin’s deep expertise in behavioral health and managed care is invaluable as we continue to expand our services nationwide.” — Dr. John Mendelson, Chief Medical Officer and Co-founder at Ria Health
SoHC's Take
Ria Health’s appointment of Dr. Martin Rosenzweig reflects a strategic move to enhance its capacity in addressing the growing demand for evidence-based Alcohol Use Disorder (AUD) treatments. His background in managed care and leadership in behavioral health initiatives, particularly around medication-assisted treatment (MAT) and psychiatric disability management, aligns with Ria Health’s mission to make comprehensive, compassionate care accessible. As alcohol misuse rates surge post-pandemic, Ria Health’s telehealth model—combining physician support, FDA-approved medications, and digital tools like Bluetooth breathalyzers—positions it at the forefront of scalable AUD treatment solutions. The board’s strengthened expertise underscores its commitment to delivering high-quality, measurable outcomes for patients nationwide.
